This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
6 - 8 June, 2023
Postillon Hotel AmsterdamDigital Experience: All Sessions Live-streamed 6-8 June, 2023

Gestur Vidarsson, Ph.D.
Head of Immunoglobulin Research/PI at Sanquin Research

Profile

Gestur Vidarsson is a principal investigator, head of Immunoglobulin Research Laboratory at Sanquin Research, a not-for-profit blood-research institute in Amsterdam, the Netherlands, and professor of Immunoglobulin biopharmaceutics at the Department of Pharmaceutical Sciences at Utrecht University. He studied molecular biology and Immunology from the University of Iceland (BSc/MSc), and obtained his PhD in Immunology at the University Medical Hospital Utrecht in 2000 under the supervision of Prof. Dr. Ingileif Jónsdóttir and Prof. Dr. Jan van de Winkel. After that he did a joint post doc at the Vaccine Research Laboratory at the RIVM and Department of Immunology of the UMCU until 2005, after which he moved to Sanquin Research in Amsterdam. His work at Sanquin has been awarded by numerous national and international grants where he studies antibody biology in its broadest sense, from the responses in B cells, to execution of immune responses, and everything in between. This work has been cited >11,000 times yielding a h-index of 53, with 121 papers cited more than 10 times in the last 5 years. This includes work in autoimmunity, vaccines, infectious diseases, cancer, on Fc-receptors (myeloid and NK cell Ig-receptors including FcRn), complement, and antibody glycosylation. To do study IgG glycosylation we have pioneered techniques to investigate antigen-specific IgG glycosylation analysis with Prof. Manfred Wuhrer and glycoengineering, in conjunction with single cell B cell techniques. We are also actively putting these tools to use for diagnostic purposes in antibody testing in pregnancy and for therapeutic purposes, where we also collaborate with the antibody pharmaceutical industry.

Agenda Sessions

  • IgG Glycosylation Steering Fc-receptor and Complement Activities

    10:00